Our current special focus is on identification and assessment of residual risk factors such as small, dense LDL and Remnant lipoproteins

See More


See video of our special focus on identification and assessment of residual risk factors such as small, dense LDL and Remnant lipoproteins

See Video


AACC 2019
71st AACC Annual Scientific Meeting & Clinical Lab Expo
Anaheim, CA USA
August 6 – 8, 2019

More Events


July, 2018
Denka Group to Construct a
New Manufacturing Facility
for Producing Influenza…

See More


Launching H.pylori-Latex

Helicobacter pylori colonizes in human gastric mucosa and causes chronic gastritis. It is well established that progression of inflammation leads to gastric mucosal atrophy and gastric cancer. The International Agency for Research on Cancer has recognized that H. pylori is a cause of gastric cancer and that eradication of H.pylori is a preventive measure for gastric cancer.

See More


Cardiovascular Disease Prediction
by Small, Dense LDL Cholesterol

Accurately measure small dense LDL on your Hitachi or other analyzer.
The s LDL-EX ”SEIKEN” assay quantitatively determines small, dense
low-dense lipoproteins (sdLDL), a subfraction of LDL associated with
an increased risk for cardiovascular disease (CVD).

See More
  • Reputation for innovation and quality

    Denka Seiken has been relied on for more than half a century
    for social contribution based on Immune, Antibody and Cell
    Culture Technology

  • Meeting the needs of the 21st Century

    As mankind evolves in this increasingly global environment,
    we are committed to the control of infectious diseases – always
    at the threshold of a new era.

  • Diverse solutions for human health

    Not only a manufacturer of vaccines for human use, but
    we offer varied product lines, services, and in-depth knowledge
    to hospitals and clinics.

  • Denka Seiken possesses numerous
    collaborative business connections

    We are connected with the world-wide top ten diagnostic companies for a number of products including FDA-clearance for sales in the US.

  • Innovative Leadership

    We offer highly original products of excellent quality in a
    variety of fields, including clinical chemistry, immunochemistry,
    and infectious disease IVD reagents.

  • Total Commitment to R&D

    Denka Seiken effectively utilizes resources through commitment
    to R&D and enhances technological capabilities for the promotion
    of health.